Malignant Peritoneal Neoplasm Completed Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00491855Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisTreatment
NCT00672295PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal CancerTreatment